Long-term data of the new transcutaneous partially implantable bone conduction hearing system Osia
Purpose The new active transcutaneous partially implantable osseointegrated system Cochlear™ Osia® System is indicated in case of conductive or mixed hearing loss (CHL/MHL) with a maximum average bone conduction hearing loss of 55 dB, or in single-sided deafness (SSD). The implant directly stimulate...
Gespeichert in:
| Veröffentlicht in: | European archives of oto-rhino-laryngology 2022-09, Vol.279 (9), p.4279-4288 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 4288 |
|---|---|
| container_issue | 9 |
| container_start_page | 4279 |
| container_title | European archives of oto-rhino-laryngology |
| container_volume | 279 |
| creator | Rauch, Ann-Kathrin Wesarg, Thomas Aschendorff, Antje Speck, Iva Arndt, Susan |
| description | Purpose
The new active transcutaneous partially implantable osseointegrated system Cochlear™ Osia® System is indicated in case of conductive or mixed hearing loss (CHL/MHL) with a maximum average bone conduction hearing loss of 55 dB, or in single-sided deafness (SSD). The implant directly stimulates the bone via a piezoelectric transducer and is directed by an external sound processor. We conducted a monocentric retrospective longitudinal within-subject clinical study at our tertiary academic referral center. The aim was to investigate long-term data (2017–2021) on audiological outcomes and hearing-related quality of life for the Osia system.
Methods
Between 2017 and 2020, 22 adults (18: CHL/MHL; 3: SSD) were implanted with the Osia100 implant; seven received bilateral implants. As of 10/2020, the sound processor was upgraded to Osia 2.
Results
Mean Osia system use by 04/2021 was 30.9 ± 8.6 months (range 17–40 months). Unaided bone conduction thresholds were unchanged postoperatively. One patient had to be explanted because of prolonged wound infection. Aided hearing thresholds were significantly lower compared to the unaided thresholds preoperatively, along with a marked increase in speech recognition in quiet. Speech processor upgrade resulted in a stable benefit. Patients with CHL/MHL and SSD showed a similar improvement in self-rated hearing performance revealed by SSQ, APHAB, and HUI questionnaires.
Conclusion
The Osia system is a safe, effective and sustainable option for treatment of conductive and mixed hearing loss or single-sided deafness. |
| doi_str_mv | 10.1007/s00405-021-07167-9 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9363475</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2599076464</sourcerecordid><originalsourceid>FETCH-LOGICAL-c446t-82463eba21fd6dba465399ecfb9e47da112a360ad1c9c0fd7afce73465a821163</originalsourceid><addsrcrecordid>eNp9kb2O1DAUhS0EYoeBF6BALmkC_os9bpDQij9ppG2gtm6cmxmvEjvYDmjenixZVtBQufDnc33PR8hLzt5wxszbwphibcMEb5jh2jT2EdlxJVWjjNCPyY5ZaRqljLkiz0q5ZYy1ysqn5EoqY4UWhx3pjimemop5oj1UoGmg9Yw04k9aM8TilwoR01LoDLkGGMcLDdM8QqzQjUi7FJH6FPvF15AiPSPkEE-0XErFid6UAM_JkwHGgi_uzz359vHD1-vPzfHm05fr98fGK6VrcxBKS-xA8KHXfQdKt9Ja9ENnUZkeOBcgNYOee-vZ0BsYPBq5YnAQnGu5J--23HnpJuw9xnWD0c05TJAvLkFw_97EcHan9MNZqddC2jXg9X1ATt8XLNVNoXgcx60BJ1prmdFKqxUVG-pzKiXj8DCGM3cnx21y3CrH_ZazTtmTV39_8OHJHxsrIDegzHclYna3aclxLe1_sb8AC2iduQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2599076464</pqid></control><display><type>article</type><title>Long-term data of the new transcutaneous partially implantable bone conduction hearing system Osia</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Rauch, Ann-Kathrin ; Wesarg, Thomas ; Aschendorff, Antje ; Speck, Iva ; Arndt, Susan</creator><creatorcontrib>Rauch, Ann-Kathrin ; Wesarg, Thomas ; Aschendorff, Antje ; Speck, Iva ; Arndt, Susan</creatorcontrib><description>Purpose
The new active transcutaneous partially implantable osseointegrated system Cochlear™ Osia® System is indicated in case of conductive or mixed hearing loss (CHL/MHL) with a maximum average bone conduction hearing loss of 55 dB, or in single-sided deafness (SSD). The implant directly stimulates the bone via a piezoelectric transducer and is directed by an external sound processor. We conducted a monocentric retrospective longitudinal within-subject clinical study at our tertiary academic referral center. The aim was to investigate long-term data (2017–2021) on audiological outcomes and hearing-related quality of life for the Osia system.
Methods
Between 2017 and 2020, 22 adults (18: CHL/MHL; 3: SSD) were implanted with the Osia100 implant; seven received bilateral implants. As of 10/2020, the sound processor was upgraded to Osia 2.
Results
Mean Osia system use by 04/2021 was 30.9 ± 8.6 months (range 17–40 months). Unaided bone conduction thresholds were unchanged postoperatively. One patient had to be explanted because of prolonged wound infection. Aided hearing thresholds were significantly lower compared to the unaided thresholds preoperatively, along with a marked increase in speech recognition in quiet. Speech processor upgrade resulted in a stable benefit. Patients with CHL/MHL and SSD showed a similar improvement in self-rated hearing performance revealed by SSQ, APHAB, and HUI questionnaires.
Conclusion
The Osia system is a safe, effective and sustainable option for treatment of conductive and mixed hearing loss or single-sided deafness.</description><identifier>ISSN: 0937-4477</identifier><identifier>ISSN: 1434-4726</identifier><identifier>EISSN: 1434-4726</identifier><identifier>DOI: 10.1007/s00405-021-07167-9</identifier><identifier>PMID: 34792628</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Adult ; Bone Conduction ; Deafness ; Head and Neck Surgery ; Hearing Aids ; Hearing Loss ; Hearing Loss, Conductive - surgery ; Hearing Loss, Mixed Conductive-Sensorineural - surgery ; Humans ; Medicine ; Medicine & Public Health ; Neurosurgery ; Otology ; Otorhinolaryngology ; Quality of Life ; Retrospective Studies ; Speech Perception ; Treatment Outcome</subject><ispartof>European archives of oto-rhino-laryngology, 2022-09, Vol.279 (9), p.4279-4288</ispartof><rights>The Author(s) 2021</rights><rights>2021. The Author(s).</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c446t-82463eba21fd6dba465399ecfb9e47da112a360ad1c9c0fd7afce73465a821163</citedby><cites>FETCH-LOGICAL-c446t-82463eba21fd6dba465399ecfb9e47da112a360ad1c9c0fd7afce73465a821163</cites><orcidid>0000-0003-3333-5387</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00405-021-07167-9$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00405-021-07167-9$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34792628$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rauch, Ann-Kathrin</creatorcontrib><creatorcontrib>Wesarg, Thomas</creatorcontrib><creatorcontrib>Aschendorff, Antje</creatorcontrib><creatorcontrib>Speck, Iva</creatorcontrib><creatorcontrib>Arndt, Susan</creatorcontrib><title>Long-term data of the new transcutaneous partially implantable bone conduction hearing system Osia</title><title>European archives of oto-rhino-laryngology</title><addtitle>Eur Arch Otorhinolaryngol</addtitle><addtitle>Eur Arch Otorhinolaryngol</addtitle><description>Purpose
The new active transcutaneous partially implantable osseointegrated system Cochlear™ Osia® System is indicated in case of conductive or mixed hearing loss (CHL/MHL) with a maximum average bone conduction hearing loss of 55 dB, or in single-sided deafness (SSD). The implant directly stimulates the bone via a piezoelectric transducer and is directed by an external sound processor. We conducted a monocentric retrospective longitudinal within-subject clinical study at our tertiary academic referral center. The aim was to investigate long-term data (2017–2021) on audiological outcomes and hearing-related quality of life for the Osia system.
Methods
Between 2017 and 2020, 22 adults (18: CHL/MHL; 3: SSD) were implanted with the Osia100 implant; seven received bilateral implants. As of 10/2020, the sound processor was upgraded to Osia 2.
Results
Mean Osia system use by 04/2021 was 30.9 ± 8.6 months (range 17–40 months). Unaided bone conduction thresholds were unchanged postoperatively. One patient had to be explanted because of prolonged wound infection. Aided hearing thresholds were significantly lower compared to the unaided thresholds preoperatively, along with a marked increase in speech recognition in quiet. Speech processor upgrade resulted in a stable benefit. Patients with CHL/MHL and SSD showed a similar improvement in self-rated hearing performance revealed by SSQ, APHAB, and HUI questionnaires.
Conclusion
The Osia system is a safe, effective and sustainable option for treatment of conductive and mixed hearing loss or single-sided deafness.</description><subject>Adult</subject><subject>Bone Conduction</subject><subject>Deafness</subject><subject>Head and Neck Surgery</subject><subject>Hearing Aids</subject><subject>Hearing Loss</subject><subject>Hearing Loss, Conductive - surgery</subject><subject>Hearing Loss, Mixed Conductive-Sensorineural - surgery</subject><subject>Humans</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Neurosurgery</subject><subject>Otology</subject><subject>Otorhinolaryngology</subject><subject>Quality of Life</subject><subject>Retrospective Studies</subject><subject>Speech Perception</subject><subject>Treatment Outcome</subject><issn>0937-4477</issn><issn>1434-4726</issn><issn>1434-4726</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><recordid>eNp9kb2O1DAUhS0EYoeBF6BALmkC_os9bpDQij9ppG2gtm6cmxmvEjvYDmjenixZVtBQufDnc33PR8hLzt5wxszbwphibcMEb5jh2jT2EdlxJVWjjNCPyY5ZaRqljLkiz0q5ZYy1ysqn5EoqY4UWhx3pjimemop5oj1UoGmg9Yw04k9aM8TilwoR01LoDLkGGMcLDdM8QqzQjUi7FJH6FPvF15AiPSPkEE-0XErFid6UAM_JkwHGgi_uzz359vHD1-vPzfHm05fr98fGK6VrcxBKS-xA8KHXfQdKt9Ja9ENnUZkeOBcgNYOee-vZ0BsYPBq5YnAQnGu5J--23HnpJuw9xnWD0c05TJAvLkFw_97EcHan9MNZqddC2jXg9X1ATt8XLNVNoXgcx60BJ1prmdFKqxUVG-pzKiXj8DCGM3cnx21y3CrH_ZazTtmTV39_8OHJHxsrIDegzHclYna3aclxLe1_sb8AC2iduQ</recordid><startdate>20220901</startdate><enddate>20220901</enddate><creator>Rauch, Ann-Kathrin</creator><creator>Wesarg, Thomas</creator><creator>Aschendorff, Antje</creator><creator>Speck, Iva</creator><creator>Arndt, Susan</creator><general>Springer Berlin Heidelberg</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3333-5387</orcidid></search><sort><creationdate>20220901</creationdate><title>Long-term data of the new transcutaneous partially implantable bone conduction hearing system Osia</title><author>Rauch, Ann-Kathrin ; Wesarg, Thomas ; Aschendorff, Antje ; Speck, Iva ; Arndt, Susan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c446t-82463eba21fd6dba465399ecfb9e47da112a360ad1c9c0fd7afce73465a821163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adult</topic><topic>Bone Conduction</topic><topic>Deafness</topic><topic>Head and Neck Surgery</topic><topic>Hearing Aids</topic><topic>Hearing Loss</topic><topic>Hearing Loss, Conductive - surgery</topic><topic>Hearing Loss, Mixed Conductive-Sensorineural - surgery</topic><topic>Humans</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Neurosurgery</topic><topic>Otology</topic><topic>Otorhinolaryngology</topic><topic>Quality of Life</topic><topic>Retrospective Studies</topic><topic>Speech Perception</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rauch, Ann-Kathrin</creatorcontrib><creatorcontrib>Wesarg, Thomas</creatorcontrib><creatorcontrib>Aschendorff, Antje</creatorcontrib><creatorcontrib>Speck, Iva</creatorcontrib><creatorcontrib>Arndt, Susan</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>European archives of oto-rhino-laryngology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rauch, Ann-Kathrin</au><au>Wesarg, Thomas</au><au>Aschendorff, Antje</au><au>Speck, Iva</au><au>Arndt, Susan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-term data of the new transcutaneous partially implantable bone conduction hearing system Osia</atitle><jtitle>European archives of oto-rhino-laryngology</jtitle><stitle>Eur Arch Otorhinolaryngol</stitle><addtitle>Eur Arch Otorhinolaryngol</addtitle><date>2022-09-01</date><risdate>2022</risdate><volume>279</volume><issue>9</issue><spage>4279</spage><epage>4288</epage><pages>4279-4288</pages><issn>0937-4477</issn><issn>1434-4726</issn><eissn>1434-4726</eissn><abstract>Purpose
The new active transcutaneous partially implantable osseointegrated system Cochlear™ Osia® System is indicated in case of conductive or mixed hearing loss (CHL/MHL) with a maximum average bone conduction hearing loss of 55 dB, or in single-sided deafness (SSD). The implant directly stimulates the bone via a piezoelectric transducer and is directed by an external sound processor. We conducted a monocentric retrospective longitudinal within-subject clinical study at our tertiary academic referral center. The aim was to investigate long-term data (2017–2021) on audiological outcomes and hearing-related quality of life for the Osia system.
Methods
Between 2017 and 2020, 22 adults (18: CHL/MHL; 3: SSD) were implanted with the Osia100 implant; seven received bilateral implants. As of 10/2020, the sound processor was upgraded to Osia 2.
Results
Mean Osia system use by 04/2021 was 30.9 ± 8.6 months (range 17–40 months). Unaided bone conduction thresholds were unchanged postoperatively. One patient had to be explanted because of prolonged wound infection. Aided hearing thresholds were significantly lower compared to the unaided thresholds preoperatively, along with a marked increase in speech recognition in quiet. Speech processor upgrade resulted in a stable benefit. Patients with CHL/MHL and SSD showed a similar improvement in self-rated hearing performance revealed by SSQ, APHAB, and HUI questionnaires.
Conclusion
The Osia system is a safe, effective and sustainable option for treatment of conductive and mixed hearing loss or single-sided deafness.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>34792628</pmid><doi>10.1007/s00405-021-07167-9</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0003-3333-5387</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0937-4477 |
| ispartof | European archives of oto-rhino-laryngology, 2022-09, Vol.279 (9), p.4279-4288 |
| issn | 0937-4477 1434-4726 1434-4726 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9363475 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Adult Bone Conduction Deafness Head and Neck Surgery Hearing Aids Hearing Loss Hearing Loss, Conductive - surgery Hearing Loss, Mixed Conductive-Sensorineural - surgery Humans Medicine Medicine & Public Health Neurosurgery Otology Otorhinolaryngology Quality of Life Retrospective Studies Speech Perception Treatment Outcome |
| title | Long-term data of the new transcutaneous partially implantable bone conduction hearing system Osia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T18%3A07%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-term%20data%20of%20the%20new%20transcutaneous%20partially%20implantable%20bone%20conduction%20hearing%20system%20Osia&rft.jtitle=European%20archives%20of%20oto-rhino-laryngology&rft.au=Rauch,%20Ann-Kathrin&rft.date=2022-09-01&rft.volume=279&rft.issue=9&rft.spage=4279&rft.epage=4288&rft.pages=4279-4288&rft.issn=0937-4477&rft.eissn=1434-4726&rft_id=info:doi/10.1007/s00405-021-07167-9&rft_dat=%3Cproquest_pubme%3E2599076464%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2599076464&rft_id=info:pmid/34792628&rfr_iscdi=true |